• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.53% Nasdaq Up 0.11%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    187.33 Up 1.09(0.59%) 4:00PM EDT
    |After Hours : 187.33 0.00 (0.00%) 4:47PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:186.24
    Open:187.05
    Bid:184.78 x 100
    Ask:187.29 x 100
    1y Target Est:220.00
    Beta:1.44
    Earnings Date:Jul 22 - Jul 27 (Est.)
    Day's Range:185.01 - 188.73
    52wk Range:150.06 - 203.30
    Volume:1,808,917
    Avg Vol (3m):2,149,140
    Market Cap:41.98B
    P/E (ttm):64.18
    EPS (ttm):2.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALXN

    Comparison

    Symbol% ChgMkt Cap
    ALXNUp 0.59%41.98B
    AMGNUp 0.58%118.15B
    BAXDown 2.44%20.17B

    Key Statistics

    Forward P/E (1 yr):31.27
    P/S (ttm):16.39
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :4.98
    Quarterly EPS Est (Jun-15) :1.38
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):2.11

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback